ENCEFALITES AUTOIMUNES – ABORDAGEM PRÁTICA PARA SITUAÇÕES DE RECURSOS LIMITADOS

Autores

  • Christian Pereira Gregory Universidade Federal de Santa Catarina https://orcid.org/0000-0003-3053-7565
  • Adaucto Wanderley Nóbrega Jr Universidade Federal de Santa Catarina
  • Katia Lin Universidade Federal de Santa Catarina

DOI:

https://doi.org/10.32963/bcmufsc.v5i2.3488

Palavras-chave:

encefalite, encefalite autoimune, autoimunidade

Resumo

As encefalites autoimunes são um grupo de doenças causadas por autoanticorpos contra antígenos neuronais. Nos últimos dez anos, surgiram várias publicações que possibilitaram classificar e tratar pacientes com quadros de encefalites que antes eram irreconhecíveis e fatais. Estima-se que as causas autoimunes são responsáveis por 20% de todas as encefalites. Pelo fato de o diagnóstico ser bastante dependente de testes imunológicos de difícil acesso no SUS, este trabalho apresenta uma revisão não sistemática, com o enfoque em uma abordagem clínica dessas doenças, de modo prático, que agilize o diagnóstico destas emergências neurológicas, mesmo em locais de recursos limitados. A pesquisa da literatura foi baseada na base de dados do PubMed, Medline.

Biografia do Autor

Christian Pereira Gregory, Universidade Federal de Santa Catarina

Acadêmico do curso de Medicina da UFSC - Universidade Federal de Santa Catarina.

Referências

Lancaster E, Dalmau J. Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 2012;8(7):380–90.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391–404.

Granerod J, Ambrose HE, Davies NWS, Clewley JP, Walsh AL, Morgan D, et al. Causes of encephalitis and differences in their clinical presentations in England: A multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835–44.

Dutra LA, Abrantes F, Toso FF, Pedroso JL, Barsottini OGP, Hoftberger R. Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr. 2018;76(1):41–9.

Gaieski DF, O’Brien NF, Hernandez R. Emergency Neurologic Life Support: Meningitis and Encephalitis. Neurocrit Care. 2017;27:124–33.

Ankersmit HJ, Felipe A De, Saiz A. Encephalitis and GABA B receptor antibodies. Neurology. 2013;81:1–7.

Van Coevorden-Hameete MH, de Graaff E, Titulaer MJ, Hoogenraad CC, Sillevis Smitt PAE. Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system. Autoimmun Rev. 2014;13(3):299–312.

Linnoila JJ, Binnicker MJ, Majed M, Klein CJ, McKeon A. CSF herpes virus and autoantibody profiles in the evaluation of encephalitis. Neurol - Neuroimmunol Neuroinflammation. 2016;3(4):e245.

Frank Leypoldt , Klaus-Peter Wandinger, Christian G Bien and JD. Autoimmune Encephalitis HHS. Eur Neurol Rev. 2013;8(1):31–7.

Dalmau J, Rosenfeld MR, DeAngelis LM, Eichler AF. Paraneoplastic and autoimmune encephalitis. Uptodate. 2017;(December):1–22.

Davis R, Dalmau J. Autoimmunity, seizures, and status epilepticus. Epilepsia. 2013;54(SUPPL. 6):46–9.

Nóbrega-Jr AW, Gregory CP, Schlindwein-Zanini R, Neves F de S, Wolf P, Walz R, et al. Mesial temporal lobe epilepsy with hippocampal sclerosis is infrequently associated with neuronal autoantibodies. Epilepsia. 2018;59(9):e152–6.

Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res. 2016;176(1):36–40.

Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study. Lancet Neurol. 2013;12(2):157–65.

Gresa-Arribas N, Planagumà J, Petit-Pedrol M, Kawachi I, Katada S, Glaser CA, et al. Human neurexin-3α antibodies associate with encephalitis and alter synapse development. Neurology. 2016;86(24):2235–42.

Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012;135(11):3453–68.

Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: A novel meningoencephalomyelitis. JAMA Neurol. 2016;73(11):1297–307.

Kelley BP, Patel SC, Marin HL, Corrigan JJ, Mitsias PD, Griffith B. Autoimmune encephalitis: Pathophysiology and imaging review of an overlooked diagnosis. Am J Neuroradiol. 2017;38(6):1070–8.

Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ. Extreme delta brush receptor encephalitis. Neurology. 2012;79:1094–100.

Lizcano A, Carriço L, Barbosa P, Carvalho MI, Yasuda C, Montenegro MA, et al. EEG and magnetic resonance imaging abnormalities in patients with acute limbic encephalitis. J Epilepsy Clin Neurophysiol. 2011;17(4):133–9.

Dubey D, Blackburn K, Greenberg B, Stuve O, Vernino S. Diagnostic and therapeutic strategies for management of autoimmune encephalopathies. Expert Rev Neurother. 2016;16(8):937–49.

Forsström B, Bisławska Axnäs B, Rockberg J, Danielsson H, Bohlin A, Uhlen M. Dissecting antibodies with regards to linear and conformational epitopes. PLoS One. 2015;10(3):1–11.

Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the CNS: New developments and future challenges. Lancet Neurol. 2011;10(8):759–72.

Dahm L, Ott C, Steiner J, Stepniak B. Seroprevalence of autoantibodies against brain antigens in health and disease. :1–23.

Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAAreceptor: A case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13(3):276–86.

Payer J, Petrovic T, Lisy L, Langer P. Hashimoto encephalopathy: A rare intricate syndrome. Int J Endocrinol Metab. 2012;10(2):506–14.

Titulaer MJ, Soffietti R, Dalmau J, Gilhus NE, Giometto B, Graus F, et al. Screening for tumours in paraneoplastic syndromes: Report of an EFNS Task Force. Eur J Neurol. 2011;18(1):19–27.

Marshall GA, Doyle JJ. Long-Term Treatment of Hashimoto’s Encephalopathy. J Neuropsychiatry Clin Neurosci. 2006;18(1):14–20.

Prüss H, Dalmau J, Harms L, Höltje M, Ahnert-Hilger G, Borowski K, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010;75(19):1735–9.

Bale JF. Virus and Immune-Mediated Encephalitides: Epidemiology, Diagnosis, Treatment, and Prevention. Pediatr Neurol. 2015;53(1):3–12.

Downloads

Publicado

2019-05-25

Edição

Seção

Artigos de revisão